Analysts are adjusting their Q1 2025 earnings forecasts for several companies, including Workiva, Titan International, Expro Group, Zimmer Biomet, and Zevia PBC. Also, IFP Advisors Inc. reduced its stake in Norwegian Cruise Line Holdings Ltd. Read more...

Analyst updates include lowered EPS estimates for Epsilon Energy (EPSN) by Roth Capital, reduced holdings in Vanguard Mortgage-Backed Securities ETF (VMBS) by IFP Advisors, FY2029 EPS estimates for Schrödinger (SDGR) by Leerink Partnrs, and Q1 2025 earnings estimates for Trulieve Cannabis (TRU) by Roth Capital. Read more...

B. Riley adjusts estimates for several companies, including upgrading New York Mortgage Trust, forecasting UMH Properties' Q1 earnings, and revising earnings per share for Montauk Renewables and Ameresco. Read more...

Recent analyst actions have stirred the tech stock market, with upgrades and downgrades impacting companies like Viridian Therapeutics, Denali, GigaCloud, Intellia, Micron, and VEON. Read more...

A look at the latest earnings estimates and analyst outlook for several companies including Alphabet, Rocket Pharmaceuticals, Pharming Group, Structure Therapeutics, uCloudlink Group, and Longeveron. Read more...

This article summarizes recent market activity, including Whipplewood Advisors' investment in Meta, analyst rating changes for Mattel and Noodles & Company, and Wedbush's updated earnings estimates for Apellis Pharmaceuticals. Read more...

A dying man's estate was left to his hospice nurse, raising questions about potential exploitation and the legal implications of such relationships. Plus, tips for expats investing abroad. Read more...

Scotiabank's recent analyst actions have significantly impacted several companies, with upgrades and downgrades affecting stock prices for firms like AT&T, Janux Therapeutics, and others. Read more...

A roundup of the latest business news, including earnings estimate adjustments for Canadian companies, upcoming CPP payments, and potential delays in the TikTok sale. Read more...

William Blair reaffirmed ratings for AvePoint and Biodesix, reiterated a "market perform" for Fortrea, and issued Q1 earnings forecast for Rocket Pharmaceuticals. Read more...

Tesla faces mixed fortunes: TSLY's high yield may persist despite volatility, EU sales are down amidst Elon Musk's controversies, yet Wall Street sees AI potential. Read more...

National Bank Financial analysts have adjusted their earnings per share (EPS) estimates for several Canadian companies, including Candente Copper, Premium Brands, Stella-Jones, and Boralex. The updates reflect a mixed outlook across various sectors. Read more...

A brief overview of recent stock market activity involving Tesla, CrowdStrike, Take-Two Interactive, and RiceBran Technologies, highlighting analyst estimates and investment firm actions. Read more...